Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

Barriers and facilitators to implementing cancer prevention clinical decision support in primary care: a qualitative study.

Harry ML, Truitt AR, Saman DM, Henzler-Buckingham HA, Allen CI, Walton KM, Ekstrom HL, O'Connor PJ, Sperl-Hillen JM, Bianco JA, Elliott TE.

BMC Health Serv Res. 2019 Jul 31;19(1):534. doi: 10.1186/s12913-019-4326-4.

2.

Methane gas transport in unconfined aquifers: A numerical sensitivity study of a controlled release experiment at CFB Borden.

Klazinga DR, Steelman CM, Cahill AG, Walton KM, Endres AL, Parker BL.

J Contam Hydrol. 2019 Aug;225:103506. doi: 10.1016/j.jconhyd.2019.103506. Epub 2019 May 30.

PMID:
31181538
3.

Meta-analysis of naturalistic developmental behavioral interventions for young children with autism spectrum disorder.

Tiede G, Walton KM.

Autism. 2019 Nov;23(8):2080-2095. doi: 10.1177/1362361319836371. Epub 2019 Apr 24.

PMID:
31018655
4.

Leisure time and family functioning in families living with autism spectrum disorder.

Walton KM.

Autism. 2019 Aug;23(6):1384-1397. doi: 10.1177/1362361318812434. Epub 2018 Nov 22.

PMID:
30466294
5.

Efficacy of low intensity, therapist-implemented Project ImPACT for increasing social communication skills in young children with ASD.

Ingersoll BR, Wainer AL, Berger NI, Walton KM.

Dev Neurorehabil. 2017 Nov;20(8):502-510. doi: 10.1080/17518423.2016.1278054. Epub 2017 Feb 2.

PMID:
28152327
6.
7.

The utility of Thin Slice ratings for predicting language growth in children with autism spectrum disorder.

Walton KM, Ingersoll BR.

Autism. 2016 Apr;20(3):374-80. doi: 10.1177/1362361315584465. Epub 2015 May 19.

PMID:
25991846
8.

Psychosocial Adjustment and Sibling Relationships in Siblings of Children with Autism Spectrum Disorder: Risk and Protective Factors.

Walton KM, Ingersoll BR.

J Autism Dev Disord. 2015 Sep;45(9):2764-78. doi: 10.1007/s10803-015-2440-7.

PMID:
25847756
9.

NIH electronic cigarette workshop: developing a research agenda.

Walton KM, Abrams DB, Bailey WC, Clark D, Connolly GN, Djordjevic MV, Eissenberg TE, Fiore MC, Goniewicz ML, Haverkos L, Hecht SS, Henningfield JE, Hughes JR, Oncken CA, Postow L, Rose JE, Wanke KL, Yang L, Hatsukami DK.

Nicotine Tob Res. 2015 Feb;17(2):259-69. doi: 10.1093/ntr/ntu214. Epub 2014 Oct 21.

10.
11.

Modeling and validating chronic pharmacological manipulation of circadian rhythms.

Kim JK, Forger DB, Marconi M, Wood D, Doran A, Wager T, Chang C, Walton KM.

CPT Pharmacometrics Syst Pharmacol. 2013 Jul 17;2:e57. doi: 10.1038/psp.2013.34.

12.

Evaluation of a Sibling-Mediated Imitation Intervention for Young Children with Autism.

Walton KM, Ingersoll BR.

J Posit Behav Interv. 2012 Oct;14(4). doi: 10.1177/1098300712437044.

13.

Improving social skills in adolescents and adults with autism and severe to profound intellectual disability: a review of the literature.

Walton KM, Ingersoll BR.

J Autism Dev Disord. 2013 Mar;43(3):594-615. doi: 10.1007/s10803-012-1601-1. Review.

PMID:
22790427
14.

Classification of threespine stickleback along the benthic-limnetic axis.

Willacker JJ, von Hippel FA, Wilton PR, Walton KM.

Biol J Linn Soc Lond. 2010 Nov 1;101(3):595-608.

15.

Entrainment of disrupted circadian behavior through inhibition of casein kinase 1 (CK1) enzymes.

Meng QJ, Maywood ES, Bechtold DA, Lu WQ, Li J, Gibbs JE, Dupré SM, Chesham JE, Rajamohan F, Knafels J, Sneed B, Zawadzke LE, Ohren JF, Walton KM, Wager TT, Hastings MH, Loudon AS.

Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15240-5. doi: 10.1073/pnas.1005101107. Epub 2010 Aug 9.

16.

Selective inhibition of casein kinase 1 epsilon minimally alters circadian clock period.

Walton KM, Fisher K, Rubitski D, Marconi M, Meng QJ, Sládek M, Adams J, Bass M, Chandrasekaran R, Butler T, Griffor M, Rajamohan F, Serpa M, Chen Y, Claffey M, Hastings M, Loudon A, Maywood E, Ohren J, Doran A, Wager TT.

J Pharmacol Exp Ther. 2009 Aug;330(2):430-9. doi: 10.1124/jpet.109.151415. Epub 2009 May 19.

PMID:
19458106
17.

Galanin function in the central nervous system.

Walton KM, Chin JE, Duplantier AJ, Mather RJ.

Curr Opin Drug Discov Devel. 2006 Sep;9(5):560-70. Review.

PMID:
17002216
18.

Rescue of hearing, auditory hair cells, and neurons by CEP-1347/KT7515, an inhibitor of c-Jun N-terminal kinase activation.

Pirvola U, Xing-Qun L, Virkkala J, Saarma M, Murakata C, Camoratto AM, Walton KM, Ylikoski J.

J Neurosci. 2000 Jan 1;20(1):43-50.

19.
20.

Immunolocalization of the mitogen-activated protein kinases p42MAPK and JNK1, and their regulatory kinases MEK1 and MEK4, in adult rat central nervous system.

Flood DG, Finn JP, Walton KM, Dionne CA, Contreras PC, Miller MS, Bhat RV.

J Comp Neurol. 1998 Aug 31;398(3):373-92.

PMID:
9714150
21.

Activation of p38MAPK in microglia after ischemia.

Walton KM, DiRocco R, Bartlett BA, Koury E, Marcy VR, Jarvis B, Schaefer EM, Bhat RV.

J Neurochem. 1998 Apr;70(4):1764-7.

22.

Region-specific targets of p42/p44MAPK signaling in rat brain.

Bhat RV, Engber TM, Finn JP, Koury EJ, Contreras PC, Miller MS, Dionne CA, Walton KM.

J Neurochem. 1998 Feb;70(2):558-71.

23.

Motoneuron apoptosis is blocked by CEP-1347 (KT 7515), a novel inhibitor of the JNK signaling pathway.

Maroney AC, Glicksman MA, Basma AN, Walton KM, Knight E Jr, Murphy CA, Bartlett BA, Finn JP, Angeles T, Matsuda Y, Neff NT, Dionne CA.

J Neurosci. 1998 Jan 1;18(1):104-11.

24.

PTP NE-6: a brain-enriched receptor-type protein tyrosine phosphatase with a divergent catalytic domain.

Fitzgerald LR, Walton KM, Dixon JE, Largent BL.

J Neurochem. 1997 May;68(5):1820-9.

25.
26.

A novel receptor-type protein tyrosine phosphatase is expressed during neurogenesis in the olfactory neuroepithelium.

Walton KM, Martell KJ, Kwak SP, Dixon JE, Largent BL.

Neuron. 1993 Aug;11(2):387-400.

27.

Protein tyrosine phosphatases.

Walton KM, Dixon JE.

Annu Rev Biochem. 1993;62:101-20. Review. No abstract available.

PMID:
8352585
28.
30.

The cAMP-regulated enhancer-binding protein ATF-1 activates transcription in response to cAMP-dependent protein kinase A.

Rehfuss RP, Walton KM, Loriaux MM, Goodman RH.

J Biol Chem. 1991 Oct 5;266(28):18431-4.

31.

Molecular mechanisms of cAMP-regulated gene expression.

Walton KM, Rehfuss RP.

Mol Neurobiol. 1990 Fall-Winter;4(3-4):197-210. Review.

PMID:
1966918
32.
33.

Complex ganglioside expression and tetanus toxin binding by PC12 pheochromocytoma cells.

Walton KM, Sandberg K, Rogers TB, Schnaar RL.

J Biol Chem. 1988 Feb 5;263(4):2055-63.

34.

Characterization of the binding and internalization of tetanus toxin in a neuroblastoma hybrid cell line.

Staub GC, Walton KM, Schnaar RL, Nichols T, Baichwal R, Sandberg K, Rogers TB.

J Neurosci. 1986 May;6(5):1443-51.

35.

Ganglioside glycosyltransferase assay using ion-exchange chromatography.

Walton KM, Schnaar RL.

Anal Biochem. 1986 Jan;152(1):154-9.

PMID:
3082240
36.

Carbohydrate-specific adhesion of alveolar macrophages to mannose-derivatized surfaces.

Largent BL, Walton KM, Hoppe CA, Lee YC, Schnaar RL.

J Biol Chem. 1984 Feb 10;259(3):1764-9.

37.

Techniques and concepts: independent living. Perceptions by professionals in rehabilitation.

Walton KM, Schwab LO, Cassatt-Dunn MA, Wright VK.

J Rehabil. 1980 Jul-Sep;46(3):57-63. No abstract available.

PMID:
7401093

Supplemental Content

Loading ...
Support Center